Endocrine Abstracts

Sarcopenia is a degenerative loss of skeletal muscle mass, quality, and strength. It increases the risk of falls and fractures, is associated with cardiac and respiratory disease and cognitive impairment and leads to mobility disorders. It decreases quality of life, leads to loss of independence, placement in long-term care and finally death. A variety of indices and parameters can be used to define sarcopenia. According to literature, matrix-GLA-protein (MGP) is associated wi...

Matrix–GLA–protein ( MGP), independent of its posttranslational modification(s), has been associated with bone parameters and cardiovascular risk in patients with and without type 2 diabetes mellitus (T2DM). We investigated whether uncarboxylated, dephosphorylated MGP (uc–dp MGP), total MGP or both are associated with anthropometric and cardiovascular parameters such as carotid to femoral pulse wave velocity (PWV), intima–media thickness (IMT) and relat...

BackgroundMetformin is a widely used and effective agent in type 2 diabetes mellitus (T2DM) and polycystic ovary syndrome (PCOS). Yet, the mechanisms of action and the occurrence of side effects (e.g. abdominal bloating and pain), are still poorly understood. Since organic cation transporters (OCTs) are responsible for the hepatic and renal transport of metformin, we investigated a series of short nucleotide polymorphisms (SNPs) in the OCT genes in PCOS ...